About US
Contact us
-
Pharma Technology Focus - Issue 33The rate of M&A activity in the pharma industry is showing no signs of slowing down, but will the resulting lack of healthy competition lead to a decline in research and innovation? We investigate2014/12/22
-
GSK forms new European consortium to advance Ebola vaccine candidateGlaxoSmithKline (GSK) and three leading research institutions have formed a new European consortium to help further advance development of a candidate vaccine against Ebola. The Ebola vaccine candida2014/12/19
-
Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157Chimerix, Inc. (NASDAQ: CMRX) a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc. (OTCBB: CTRV), a biopharmaceutical2014/12/19
-
High-dose flu vaccine better than regular flu shot for frail, older adults of long-term care facilitiesThe high-dose flu vaccine is significantly better than the regular flu shot at boosting the immune response to the flu virus in frail, older residents of long-term care facilities, according to the re2014/12/18
-
Pfizer and OPKO collaborate to develop and commercialise hGH-CTP to treat GHDUS-based drug maker Pfizer has signed a worldwide agreement with OPKO Health to develop and commercialise hGH-CTP to treat growth hormone deficiency (GHD) in adults and children. The agreement includ2014/12/18
-
GlaxoSmithKline Manufacturing Facility Expansion, Boronia, AustraliaGlaxoSmithKline (GSK) announced the expansion of its manufacturing facility in Boronia, in the outer eastern suburbs of Melbourne, Australia, in November 2014. The expansion will introduce the latest2014/12/17
-
Nanotherapeutics to acquire Baxter’s Vero cell vaccines platformBaxter International has signed an agreement with Nanotherapeutics to sell its Vero cell technology and related assets. The agreement includes its production facility in Bohumil, Czech Republic. The2014/12/17
-
Janssen and USAID collaborate to expand access to MDR-TB compoundJohnson & Johnson associate Janssen Therapeutics has signed a memorandum of understanding (MoU) with US Agency for International Development (USAID) to expand access to anti-multidrug-resistant tu2014/12/16
-
New Zealand approves Mylan-Abbott $5bn dealNew Zealand's competition watchdog Commerce Commission has approved Mylan's purchase of Abbott Laboratories's generic medicines arm Established Pharmaceuticals. The commission's clearance is limited2014/12/16
-
Sanofi receives FDA approval for Fluzone Intradermal Quadrivalent vaccine to treat influenzaSanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Fluzone Intradermal Quadrivalent vaccine. The vaccine will provide protection against four strains of influenza2014/12/16